IMIandra Luah Souza Maia

Iandra Luah Souza Maia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iandra Luah Souza Maia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral manifestations in patients undergoing chemotherapy

    by Iandra Luah Souza Maia, Rosany Larissa Brito de Oliveira, Luiz Fernando Andrade Matos, Antônio Carlos Marqueti, Geydson Silveira da Cruz, Álvaro Bezerra Cardoso

    The proposed treatment for malignant neoplasms can be isolated or combined, involving resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy induces extensive immunosuppression and affects both healthy and abnormal cells. This cytotoxicity from the treatment has a significant effect that can lead to changes in the oral mucosa. The severity is related to the type of drug, duration of treatment, dosage used, level of oral hygiene during treatment, and the individual’s age. Therefore, monitoring oral health before, during, and after antineoplastic therapy is essential. Aim: To evaluate the main oral manifestations that oncology patients presented before and after 15 days from the first administration of chemotherapy medication. Methods: A prospective observational study was conducted with 31 individuals treated at a Hospital Oncology and Hematology Service. The evaluations included the following steps: (1) Patient identification and completion of assessment forms; (2) Clinical examination of the oral cavity before and after the start of chemotherapy; and (3) Providing guidance to patients regarding oral care during oncological treatment. Results: It was observed that 70.96% of patients exhibited oral manifestations 15 days after the first infusion of antineoplastic drugs. The main changes identified included xerostomia and oral mucositis. Conclusion: Dental follow-up during chemotherapy is essential for preventing and managing potential oral emergencies, thereby avoiding interruptions in systemic treatment and ultimately enhancing the quality of life for these patients.

  • Open Access

    Efeito do raspador lingual de polietilenotereftalato na remoção da saburra lingual

    by Ramon Victor Almeida de Jesus, Shalini Singh, Iandra Luah Souza Maia, Hallana Stephanie Soares de Araújo Freire, Guilherme de Oliveira Macedo, Mônica Barbosa Leal Macedo

    O objetivo deste trabalho foi comparar um raspador de língua obtido de garrafas de polietilenotereftalato (PET) com um modelo comercial (COM). Um desenho paralelo, controlado e randomizado foi usado. Dos 61 voluntários do Departamento de Odontologia da Universidade Federal de Sergipe, 30 atenderam aos critérios de inclusão e exclusão para distribuição aleatória em 2 grupos: PET (n=15) e COM (n=15). Na consulta inicial, o Índice de Saburra Lingual de Winkel (ISL-W) foi medido antes (T0) e imediatamente após (T1) remoção da saburra lingual realizada pelo profissional, que forneceu instruções para uso caseiro do raspador 2 vezes ao dia. Após 14 dias, o ISL-W foi mensurado em T0 e T1, com remoção da saburra feita pelo participante. Dos 30, 1 do grupo COM não retornou para consulta de 14 dias. Os dados obtidos em T0 e T1 foram submetidos ao teste t-Student pareado (α=0,05). As diferenças entre T0 e T1 foram transformadas em valores percentuais e analisadas com teste t de Student não pareado (α=0,05). Os dados de T0 das consultas inicial e após 14 dias foram submetidos ao teste t-Student pareado (α=0,05). Os resultados indicaram que os 2 raspadores reduziram significantemente o ISL-W (P<0,05), com percentuais de redução semelhantes: PET (34±36%) e COM (32±22%); houve redução significante do ISL-W após 14 dias de uso caseiro dos raspadores de língua (P<0,01). Concluiu-se que o raspador de língua PET foi capaz de remover a saburra lingual, com resultados semelhantes ao COM, reduzindo o ISL-W após 14 dias de uso caseiro.

  • Open Access

    Pleomorphic adenoma treatment in a patient with neurodegenerative disease: case report

    by Iandra Luah Souza Maia, Paula Patrícia Santos Santos, Antonio Carlos Marqueti, Paulo Henrique Luiz de Freitas, Rosany Larissa Brito de Oliveira, Álvaro Bezerra Cardoso

    Pleomorphic adenoma (PA) is a benign tumor, responsible for more than 50% of the cases of salivary gland neoplasms, occurring both the major and minor salivary glands. In the oral cavity, the most frequent sites of pleomorphic adenoma are the palate and the lips, with greater preference for females and frequently affecting individuals in the fourth to fifth decade of life. The treatment of choice is based on total lesion excision with a good prognosis, which has a low potential for recurrence and malignant transformation. The objective of the study was reporting a treatment of pleomorphic adenoma localized in the hard palate of the 74-year-old male patient, F.A.S. with Parkinson’s disease. The patient is in outpatient follow-up for over a year with no signs of recurrence. Computed Tomography is an indispensable tool for directing the correct diagnosis, which is only definitive after the histopathological examination. The most indicated treatment with good prognosis is complete surgical excision of the lesion and curettage.

  • Open Access

    The importance of dental practice in oncological treatment: a case report associated with breast cancer

    by Iandra Luah Souza Maia, Rosany Larissa Brito de Oliveira, Ellen Maiany Ribeiro Santana, Paula Patrícia Santos Santos, Álvaro Bezerra Cardoso

    In Brazil, the estimated number of new cancer cases between 2020 and 2022 is 625 thousand, and the most prevalent carcinomas are primarily skin (non-melanoma), followed by those of the breast, prostate, colon, and rectum. Although breast carcinoma still has a high mortality rate, it has a good prognosis due to the increase in early diagnosis and the evolution of anticancer treatments. The proposed treatment can be isolated or associated with resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy generates extensive immunosuppression and affects both healthy and altered cells, and the cytotoxicity of the treatment is an important effect that can cause lesions on the oral mucosa. Severity is related to the type of chemotherapeutic agent, treatment time, the dose used, and the individual’s age. Additionally, chemotherapy treatment can exacerbate preexisting conditions in the individual and cause greater discomfort during treatment. Therefore, monitoring oral health before, during, and after anticancer therapy is essential. The objective of this work is to report a clinical case of dental emergency in a patient after the first cycle of doxorubicin- cyclophosphamide-paclitaxel (ACTdd) to treat breast cancer.